Sterile inflammation characterizes a heterogeneous group of primary immunodeficiency disorders named autoinflammatory diseases (AID). Less than 30% of AID patients are molecularly defined. To increase the diagnostic rate and treatment outcome in patients with undefined AID, "omics" technologies, as the next-generation sequencing and mass spectrometry, and clinical data registries analysis are applied. During the last three years, I described patients with undefined and known rare AID (i.e. RAS-associated autoimmune leukoproliferative disease and SAMD9L-associated AID), the first 100 genes and related pathways associated with AID, the actin-related AID, the syndrome of undifferentiated recurrent fever (SURF) and the proteomic signature of monocytes in hereditary recurrent fever. Furthermore, I analyzed the efficacy of the interleukin 1 inhibitors in systemic juvenile idiopathic arthritis, cryopyrin associated periodic syndrome and refractory hyperferritinemic syndromes. Finally, I developed a metadata registry called MeRITA in order to increase the interoperability and data sharing among clinical registries of the European Reference Network on Rare Immunological Disorders (ERN-RITA).

Diagnosis and treatment of patients with undefined autoinflammatory diseases

PAPA, RICCARDO
2022-05-13

Abstract

Sterile inflammation characterizes a heterogeneous group of primary immunodeficiency disorders named autoinflammatory diseases (AID). Less than 30% of AID patients are molecularly defined. To increase the diagnostic rate and treatment outcome in patients with undefined AID, "omics" technologies, as the next-generation sequencing and mass spectrometry, and clinical data registries analysis are applied. During the last three years, I described patients with undefined and known rare AID (i.e. RAS-associated autoimmune leukoproliferative disease and SAMD9L-associated AID), the first 100 genes and related pathways associated with AID, the actin-related AID, the syndrome of undifferentiated recurrent fever (SURF) and the proteomic signature of monocytes in hereditary recurrent fever. Furthermore, I analyzed the efficacy of the interleukin 1 inhibitors in systemic juvenile idiopathic arthritis, cryopyrin associated periodic syndrome and refractory hyperferritinemic syndromes. Finally, I developed a metadata registry called MeRITA in order to increase the interoperability and data sharing among clinical registries of the European Reference Network on Rare Immunological Disorders (ERN-RITA).
13-mag-2022
Autoinflammatory diseases; autoinflammation; primary immunodeficiency; interleukin; European Reference Network; RITA
File in questo prodotto:
File Dimensione Formato  
phdunige_2914178.pdf

accesso aperto

Descrizione: Tesi di dottorato
Tipologia: Tesi di dottorato
Dimensione 9.46 MB
Formato Adobe PDF
9.46 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/1080199
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact